Physician profile
Dielle L Meyer Duval
NPI 1225422322
$2,800.93
in general payments reported to CMS, 2019-2025
27 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.40 · 2021: $80.05 · 2022: $1,386 · 2023: $930 · 2024: $220 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.05 |
| Education | $190.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,083.40 | 2022-2023 | Interstim |
| Procept Biorobotics Corporation | $168.38 | 2024 | Aquabeam System |
| Axonics, INC. | $157.36 | 2022-2023 | Axonics |
| Janssen Biotech, INC. | $127.84 | 2022-2023 | Erleada |
| 180 Medical, INC. | $113.41 | 2023-2025 | Cure Catheter, Gentlecath Glide |
| Endo Pharmaceuticals INC. | $110.69 | 2022-2023 | Xiaflex, Aveed, Edex |
| Bayer Healthcare Pharmaceuticals INC. | $103.02 | 2022-2023 | |
| Astellas Pharma US INC | $97.96 | 2023 | Myrbetriq |
| Teleflex LLC | $80.05 | 2021 | |
| Boston Scientific Corporation | $79.31 | 2023-2025 | Lithovue, Rezum Generator, Lithoclast |
| Accord Healthcare, INC. | $75.06 | 2022-2023 | |
| Abbvie INC. | $74.17 | 2023-2025 | Lupron Depot, Botox |
| Sumitomo Pharma America, INC. | $68.36 | 2023 | Orgovyx, Gemtesa |
| Pfizer INC. | $55.73 | 2022-2023 | |
| Verity Pharmaceuticals INC. | $52.69 | 2022-2023 | Trelstar |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $48.73 | 2022 | |
| Rochester Medical Corporation | $48.32 | 2022 | |
| Medtronic USA, INC. | $36.40 | 2019 | |
| Coloplast Corp | $35.82 | 2022 | |
| Myovant Sciences INC. | $35.46 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Tolmar, INC. | $25.32 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $21.02 | 2023 | Bard Urinary Drainage Bag |
| Urogen Pharma, INC. | $19.60 | 2023 | Jelmyto |
| E.R. Squibb & Sons, L.L.C. | $18.45 | 2023 | Opdivo |
| Kowa Pharmaceuticals America, INC. | $15.98 | 2022 | |
| Urovant Sciences INC | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dielle Duval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.